Peer Review reports
From: PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
| Original Submission | ||
|---|---|---|
| 28 Dec 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 6 Feb 2023 | Reviewed | Reviewer Report |
| 16 Mar 2023 | Reviewed | Reviewer Report |
| 31 Mar 2023 | Author responded | Author comments - Timothy Shaw |
| Resubmission - Version 3 | ||
| 31 Mar 2023 | Submitted | Manuscript version 3 |
| 13 Apr 2023 | Author responded | Author comments - Timothy Shaw |
| Resubmission - Version 4 | ||
| 13 Apr 2023 | Submitted | Manuscript version 4 |
| 13 Apr 2023 | Author responded | Author comments - Timothy Shaw |
| Resubmission - Version 5 | ||
| 13 Apr 2023 | Submitted | Manuscript version 5 |
| 20 Apr 2023 | Reviewed | Reviewer Report |
| 28 Apr 2023 | Reviewed | Reviewer Report |
| 12 May 2023 | Author responded | Author comments - Timothy Shaw |
| Resubmission - Version 6 | ||
| 12 May 2023 | Submitted | Manuscript version 6 |
| 17 May 2023 | Reviewed | Reviewer Report |
| 23 May 2023 | Reviewed | Reviewer Report |
| 6 Jun 2023 | Author responded | Author comments - Timothy Shaw |
| Resubmission - Version 7 | ||
| 6 Jun 2023 | Submitted | Manuscript version 7 |
| 13 Jun 2023 | Reviewed | Reviewer Report |
| 18 Jun 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 8 | ||
| Submitted | Manuscript version 8 | |
| Publishing | ||
| 19 Jun 2023 | Editorially accepted | |
| 28 Jun 2023 | Article published | 10.1186/s12859-023-05393-y |
You can find further information about peer review here.